The epidermal growth factor receptor (EGFR) signaling pathway plays a critical role in the pathogenesis and progression of renal cell carcinoma [16, 17], suggested that LRRK2 may play an important role in ccRCC as well. This evidence concerns the gene EGFR and renal cell carcinoma.